Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind clinical treatment study: Naltrexone and learning model for pathological gambling
2010-021123-26Phase 3Completed
- Sponsor
- Thomas H. Lee Partners
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gambling disorder (GD) comparing Naltrexone with Placebo (2 arms). Primary endpoint: YBOCS score. Started Jun 2010; status: completed.
02
Drugs
naltrexone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on 2010-021123-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021123-26.